185 related articles for article (PubMed ID: 25796223)
1. Increased brain iron deposition is a risk factor for brain atrophy in patients with haemodialysis: a combined study of quantitative susceptibility mapping and whole brain volume analysis.
Chai C; Zhang M; Long M; Chu Z; Wang T; Wang L; Guo Y; Yan S; Haacke EM; Shen W; Xia S
Metab Brain Dis; 2015 Aug; 30(4):1009-16. PubMed ID: 25796223
[TBL] [Abstract][Full Text] [Related]
2. Quantitative measurement of brain iron deposition in patients with haemodialysis using susceptibility mapping.
Chai C; Yan S; Chu Z; Wang T; Wang L; Zhang M; Zuo C; Haacke EM; Xia S; Shen W
Metab Brain Dis; 2015 Apr; 30(2):563-71. PubMed ID: 25182196
[TBL] [Abstract][Full Text] [Related]
3. Increased iron deposition of deep cerebral gray matter structures in hemodialysis patients: A longitudinal study using quantitative susceptibility mapping.
Chai C; Wang H; Liu S; Chu ZQ; Li J; Qian T; Haacke EM; Xia S; Shen W
J Magn Reson Imaging; 2019 Mar; 49(3):786-799. PubMed ID: 30291651
[TBL] [Abstract][Full Text] [Related]
4. Quantitative measurements of brain iron deposition in cirrhotic patients using susceptibility mapping.
Xia S; Zheng G; Shen W; Liu S; Zhang LJ; Haacke EM; Lu GM
Acta Radiol; 2015 Mar; 56(3):339-46. PubMed ID: 24646625
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
[TBL] [Abstract][Full Text] [Related]
6. Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease.
Du L; Zhao Z; Cui A; Zhu Y; Zhang L; Liu J; Shi S; Fu C; Han X; Gao W; Song T; Xie L; Wang L; Sun S; Guo R; Ma G
ACS Chem Neurosci; 2018 Jul; 9(7):1849-1857. PubMed ID: 29722955
[TBL] [Abstract][Full Text] [Related]
7. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
[TBL] [Abstract][Full Text] [Related]
8. Hemisphere, gender and age-related effects on iron deposition in deep gray matter revealed by quantitative susceptibility mapping.
Gong NJ; Wong CS; Hui ES; Chan CC; Leung LM
NMR Biomed; 2015 Oct; 28(10):1267-74. PubMed ID: 26313542
[TBL] [Abstract][Full Text] [Related]
9. Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
Dusek P; Lescinskij A; Ruzicka F; Acosta-Cabronero J; Bruha R; Sieger T; Hajek M; Dezortova M
Radiology; 2021 Jun; 299(3):662-672. PubMed ID: 33754827
[TBL] [Abstract][Full Text] [Related]
10. Evaluating iron deposition in gray matter nuclei of patients with unilateral middle cerebral artery stenosis using quantitative susceptibility mapping.
Mao H; Dou W; Chen K; Wang X; Wang X; Guo Y; Zhang C
Neuroimage Clin; 2022; 34():103021. PubMed ID: 35500369
[TBL] [Abstract][Full Text] [Related]
11. Brain iron deposition in type 2 diabetes mellitus with and without mild cognitive impairment-an in vivo susceptibility mapping study.
Yang Q; Zhou L; Liu C; Liu D; Zhang Y; Li C; Shang Y; Wei X; Li C; Wang J
Brain Imaging Behav; 2018 Oct; 12(5):1479-1487. PubMed ID: 29297155
[TBL] [Abstract][Full Text] [Related]
12. Increased Brain Iron Deposition in the Putamen in Patients with Type 2 Diabetes Mellitus Detected by Quantitative Susceptibility Mapping.
Li J; Zhang Q; Zhang N; Guo L
J Diabetes Res; 2020; 2020():7242530. PubMed ID: 33062715
[TBL] [Abstract][Full Text] [Related]
13. Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2' mapping.
Qin Y; Zhu W; Zhan C; Zhao L; Wang J; Tian Q; Wang W
J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):578. PubMed ID: 21823025
[TBL] [Abstract][Full Text] [Related]
14. Regional high iron deposition on quantitative susceptibility mapping correlates with cognitive decline in type 2 diabetes mellitus.
Hu R; Gao B; Tian S; Liu Y; Jiang Y; Li W; Li Y; Song Q; Wang W; Miao Y
Front Neurosci; 2023; 17():1061156. PubMed ID: 36793541
[TBL] [Abstract][Full Text] [Related]
15. Age and sex related differences in subcortical brain iron concentrations among healthy adults.
Persson N; Wu J; Zhang Q; Liu T; Shen J; Bao R; Ni M; Liu T; Wang Y; Spincemaille P
Neuroimage; 2015 Nov; 122():385-98. PubMed ID: 26216277
[TBL] [Abstract][Full Text] [Related]
16. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
[TBL] [Abstract][Full Text] [Related]
17. Elevated brain iron is independent from atrophy in Huntington's Disease.
Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease.
van Bergen JM; Hua J; Unschuld PG; Lim IA; Jones CK; Margolis RL; Ross CA; van Zijl PC; Li X
AJNR Am J Neuroradiol; 2016 May; 37(5):789-96. PubMed ID: 26680466
[TBL] [Abstract][Full Text] [Related]
19. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.
Zivadinov R; Heininen-Brown M; Schirda CV; Poloni GU; Bergsland N; Magnano CR; Durfee J; Kennedy C; Carl E; Hagemeier J; Benedict RH; Weinstock-Guttman B; Dwyer MG
Neuroimage; 2012 Jan; 59(1):331-9. PubMed ID: 21820063
[TBL] [Abstract][Full Text] [Related]
20. Deep gray matters iron deposition is positively associated with white matter hyperintensity in hypertension.
Su Y; Wu W; Qin Z; Li C; Zhao J; Kang J; Wang Y; Zheng C; Haacke EM; Wang L
J Clin Hypertens (Greenwich); 2023 Aug; 25(8):768-777. PubMed ID: 37491795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
